Publication | Closed Access

Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents

Health SciencesGlycosylationMedicineConventional Chemotherapeutic AgentsGlycobiologyPharmacologyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchDrug Resistance